betamethasone sodium phosphate has been researched along with Uveitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, D; Keino, H; Okada, AA; Takiura, T; Yan, K | 1 |
| Akiyama, G; Higaki, M; Ishihara, T; Sakai, T; Tsuneoka, H | 1 |
| Hattori, T; Ichinose, M; Ishigaki-Suzuki, S; Nagaoka, M; Nara, M; Ogawa, H; Sasamori, K; Shimura, S; Tamada, T; Tamura, G | 1 |
| Higaki, M; Ishihara, T; Kitahara, K; Kohno, H; Matsushima, M; Mizushima, Y; Saito, S; Sakai, T | 1 |
| Eilon, LA; Walker, SR | 1 |
| Honda, Y; Hyon, SH; Ikada, Y; Kunou, N; Ogura, Y | 1 |
| Forrester, JV; Kadom, AH; Williamson, TH | 1 |
2 trial(s) available for betamethasone sodium phosphate and Uveitis
| Article | Year |
|---|---|
Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure.
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Dexamethasone; Double-Blind Method; Female; Humans; Hydrocortisone; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Random Allocation; Uveitis | 1981 |
Comparison of the anti-inflammatory activity and effect on intraocular pressure of fluoromethalone, clobetasone butyrate and betamethasone phosphate eye drops.
Topics: Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Fluorometholone; Humans; Intraocular Pressure; Middle Aged; Postoperative Complications; Uveitis | 1986 |
5 other study(ies) available for betamethasone sodium phosphate and Uveitis
| Article | Year |
|---|---|
Iatrogenic Cushing's Syndrome Due to Topical Ocular Glucocorticoid Treatment.
Topics: Betamethasone; Child; Cushing Syndrome; Female; Glucocorticoids; Humans; Iatrogenic Disease; Mutation; Ophthalmic Solutions; Receptors, Glucocorticoid; Uveitis | 2017 |
Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis.
Topics: Animals; Autoimmune Diseases; Betamethasone; Biocompatible Materials; Biological Availability; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Injections, Intravenous; Lactic Acid; Male; Microscopy, Confocal; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers; Rats; Rats, Inbred Lew; Retinitis; Tissue Distribution; Uveitis | 2011 |
Long-term use of corticosteroid eye drops delays the spontaneous remission of pulmonary sarcoidosis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Betamethasone; Case-Control Studies; Humans; Lymphatic Diseases; Ophthalmic Solutions; Peptidyl-Dipeptidase A; Remission, Spontaneous; Sarcoidosis, Pulmonary; Uveitis | 2004 |
Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate.
Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Betamethasone; Choroid; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Immunity, Cellular; Immunohistochemistry; Injections, Intravenous; Lactic Acid; Male; Microscopy, Confocal; Nanostructures; Polyesters; Polymers; Rats; Rats, Inbred Lew; Retina; Retinitis; Rhodamines; Treatment Outcome; Uveitis | 2006 |
Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate.
Topics: Animals; Betamethasone; Biocompatible Materials; Biodegradation, Environmental; Chronic Disease; Drug Delivery Systems; Drug Implants; Electroretinography; Eye; Glucocorticoids; In Vitro Techniques; Materials Testing; Microscopy, Electron, Scanning; Rabbits; Sclera; Uveitis | 2000 |